Skip to main content
Signal8

Morabito Christopher

SEC insider (Form 3/4/5 filer). CIK 0001859284. Chief Medical Officer at Astria Therapeutics, Inc. (ATXS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.

Companies Morabito Christopher has filed insider reports for

  • Astria Therapeutics, Inc. (ATXS): Officer, Chief Medical Officer
Morabito Christopher profile photo

Morabito Christopher

CIK: 0001859284

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Astria Therapeutics, Inc. logo
ATXS

Astria Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Astria Therapeutics, Inc. logo
    ATXS

    Astria Therapeutics, Inc.

    Jan 23, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    80K shares-
  • Astria Therapeutics, Inc. logo
    ATXS

    Astria Therapeutics, Inc.

    Jan 23, 2026
    Disposition

    Stock Option (Right to Buy)

    Direct
    262.5K shares-
  • Astria Therapeutics, Inc. logo
    ATXS

    Astria Therapeutics, Inc.

    Mar 21, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    262.5K shares-

1-3 of 3